BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22158075)

  • 21. Increased semaphorin 3c expression promotes tumor growth and metastasis in pancreatic ductal adenocarcinoma by activating the ERK1/2 signaling pathway.
    Xu X; Zhao Z; Guo S; Li J; Liu S; You Y; Ni B; Wang H; Bie P
    Cancer Lett; 2017 Jul; 397():12-22. PubMed ID: 28315433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of c-jun N-terminal kinase is associated with cell proliferation and shorter relapse-free period in superficial spreading malignant melanoma.
    Jørgensen K; Davidson B; Flørenes VA
    Mod Pathol; 2006 Nov; 19(11):1446-55. PubMed ID: 16951673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression and clinical significance of MAPK in non-small cell lung cancer].
    Zhang ZF; Ma JQ; Zhang L
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):339-42. PubMed ID: 15854513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival.
    Ye HL; Li DD; Lin Q; Zhou Y; Zhou QB; Zeng B; Fu ZQ; Gao WC; Liu YM; Chen RW; Li ZH; Chen RF
    World J Gastroenterol; 2015 Jun; 21(21):6621-30. PubMed ID: 26074700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ERK1/2 and p38 mitogen-activated protein kinase mediate iNOS-induced spinal neuron degeneration after acute traumatic spinal cord injury.
    Xu Z; Wang BR; Wang X; Kuang F; Duan XL; Jiao XY; Ju G
    Life Sci; 2006 Oct; 79(20):1895-905. PubMed ID: 16978658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative cognitive function predicts survival in patients with resectable pancreatic ductal adenocarcinoma.
    Baekelandt BM; Hjermstad MJ; Nordby T; Fagerland MW; Kure EH; Heiberg T; Buanes T; Labori KJ
    HPB (Oxford); 2016 Mar; 18(3):247-54. PubMed ID: 27017164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MAP2K4/MKK4 expression in pancreatic cancer: genetic validation of immunohistochemistry and relationship to disease course.
    Xin W; Yun KJ; Ricci F; Zahurak M; Qiu W; Su GH; Yeo CJ; Hruban RH; Kern SE; Iacobuzio-Donahue CA
    Clin Cancer Res; 2004 Dec; 10(24):8516-20. PubMed ID: 15623633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological correlations of nestin expression in surgically resectable pancreatic cancer including an analysis of perineural invasion.
    Lenz J; Karasek P; Jarkovsky J; Muckova K; Dite P; Kala Z; Veselska R; Hermanova M
    J Gastrointestin Liver Dis; 2011 Dec; 20(4):389-96. PubMed ID: 22187705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor recurrence is independent of pancreatic fistula in patients after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Assifi MM; Zhang S; Leiby BE; Pequignot EC; Xia B; Rosato E; Lavu H; Kennedy EP; Yeo CJ; Berger AC
    J Am Coll Surg; 2013 Oct; 217(4):621-7. PubMed ID: 23810574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure patterns in resected pancreas adenocarcinoma: lack of predicted benefit to SMAD4 expression.
    Winter JM; Tang LH; Klimstra DS; Liu W; Linkov I; Brennan MF; DʼAngelica MI; DeMatteo RP; Fong Y; Jarnagin WR; Oʼreilly EM; Allen PJ
    Ann Surg; 2013 Aug; 258(2):331-5. PubMed ID: 23360922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival.
    Nordby T; Hugenschmidt H; Fagerland MW; Ikdahl T; Buanes T; Labori KJ
    Eur J Surg Oncol; 2013 Jun; 39(6):559-66. PubMed ID: 23498362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activated Akt and Erk expression and survival after surgery in pancreatic carcinoma.
    Chadha KS; Khoury T; Yu J; Black JD; Gibbs JF; Kuvshinoff BW; Tan D; Brattain MG; Javle MM
    Ann Surg Oncol; 2006 Jul; 13(7):933-9. PubMed ID: 16788754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic relevance of activated Akt kinase in node-negative breast cancer: a clinicopathological study of 99 cases.
    Schmitz KJ; Otterbach F; Callies R; Levkau B; Hölscher M; Hoffmann O; Grabellus F; Kimmig R; Schmid KW; Baba HA
    Mod Pathol; 2004 Jan; 17(1):15-21. PubMed ID: 14631376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor size significantly correlates with postoperative liver metastases and COX-2 expression in patients with resectable pancreatic cancer.
    Matsumoto G; Muta M; Tsuruta K; Horiguchi S; Karasawa K; Okamoto A
    Pancreatology; 2007; 7(2-3):167-73. PubMed ID: 17592230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma.
    Hu D; Ansari D; Zhou Q; Sasor A; Said Hilmersson K; Andersson R
    World J Surg Oncol; 2019 Feb; 17(1):29. PubMed ID: 30736807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of Raf-1 and ERK1/2 in sacral chordoma and association with tumor recurrence.
    Zhang K; Chen H; Zhang B; Sun J; Lu J; Chen K; Yang H
    Int J Clin Exp Pathol; 2015; 8(1):608-14. PubMed ID: 25755752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low expression of junctional adhesion molecule A is associated with metastasis and poor survival in pancreatic cancer.
    Fong D; Spizzo G; Mitterer M; Seeber A; Steurer M; Gastl G; Brosch I; Moser P
    Ann Surg Oncol; 2012 Dec; 19(13):4330-6. PubMed ID: 22549289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative platelet to lymphocyte ratio predicts outcome of patients with pancreatic ductal adenocarcinoma after pancreatic resection.
    Shirai Y; Shiba H; Sakamoto T; Horiuchi T; Haruki K; Fujiwara Y; Futagawa Y; Ohashi T; Yanaga K
    Surgery; 2015 Aug; 158(2):360-5. PubMed ID: 26032829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review.
    Tamura K; Ohtsuka T; Ideno N; Aso T; Shindo K; Aishima S; Ohuchida K; Takahata S; Ushijima Y; Ito T; Oda Y; Mizumoto K; Tanaka M
    Ann Surg; 2014 Feb; 259(2):360-8. PubMed ID: 23989056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic impact of cysteine proteases cathepsin B and cathepsin L in pancreatic adenocarcinoma.
    Niedergethmann M; Wostbrock B; Sturm JW; Willeke F; Post S; Hildenbrand R
    Pancreas; 2004 Oct; 29(3):204-11. PubMed ID: 15367886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.